rhein has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, SM; Pan, WJ; Shao, C; Wang, BH; Zhao, HH; Zhao, SY | 1 |
1 other study(ies) available for rhein and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Rhein alleviates advanced glycation end products (AGEs)-induced inflammatory injury of diabetic cardiomyopathy in vitro and in vivo models.
Topics: Animals; Anthraquinones; Diabetes Mellitus; Diabetic Cardiomyopathies; Glycation End Products, Advanced; I-kappa B Kinase; NF-kappa B; Protein Serine-Threonine Kinases; Rats; TNF Receptor-Associated Factor 6 | 2023 |